Skip to content
Screener

Inspire Medical Systems INSP Q2 2025 earnings

Reported August 4, 2025 · After market close

Revenue$217.1MBeat by $2.6M
EPS$0.45Beat by $0.23
Revenue estimate$214.5M
EPS estimate$0.22

Next report

Nov 2, 2026 (in a month)
Revenue estimate$204.2M
EPS estimate$0.11

Financials

Q2 2025

Income statement

See full
Revenue$217.1M+10.8%
Gross profit$182.4M+9.9%
Operating income-$3.3M-165%
Net income-$3.6M-137%
EPS (diluted)-$0.12-138%

Balance sheet

See full
Cash & equivalents$106.9M-43.1%
Total debt$33.1M+34.9%
Total equity$677.8M+6.2%
Total assets$802.2M+10.1%

Cash flow

See full
Operating cash flow$2.7M—
CapEx$9.0M-27.4%
Free cash flow-$6.3M+49.4%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$3.91B-1.4%
Enterprise value$3.84B+0.9%
P/E73.6×—
P/S4.5×-1.1×

Profitability

See full
Gross margin84.5%-0.4pp
Operating margin4.8%—
Net margin6.2%—
FCF margin9.9%+8.8pp

Returns & leverage

See full
Return on equity8.1%—
Debt / equity0×0.0×
Current ratio6.1×-3.1×

Segments

By segment

See full
Operating Segment$217.1M+10.8%

FAQ

When did Inspire Medical Systems report Q2 2025 earnings?
Inspire Medical Systems (INSP) reported Q2 2025 earnings on August 4, 2025 after market close.
What were Inspire Medical Systems's Q2 2025 revenue and EPS?
Inspire Medical Systems reported revenue of $217.1M and eps of $0.45 for Q2 2025.
Did Inspire Medical Systems beat estimates in Q2 2025?
Revenue beat the consensus estimate of $214.5M by $2.6M. EPS beat the consensus estimate of $0.22 by $0.23.
How did Inspire Medical Systems's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.8% from $195.9M a year earlier and eps grew 40.6% from $0.32.
Where can I find Inspire Medical Systems's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001609550-25-000030) and the 10-Q periodic report (0001609550-25-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.